These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23859658)
1. Bio-orthogonal and combinatorial approaches for the design of binding growth factors. Ito Y; Tada S Biomaterials; 2013 Oct; 34(31):7565-74. PubMed ID: 23859658 [TBL] [Abstract][Full Text] [Related]
2. Rational design and protein engineering of growth factors for regenerative medicine and tissue engineering. Moss AJ; Sharma S; Brindle NP Biochem Soc Trans; 2009 Aug; 37(Pt 4):717-21. PubMed ID: 19614582 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of binding growth factors. Tada S; Kitajima T; Ito Y Int J Mol Sci; 2012; 13(5):6053-6072. PubMed ID: 22754349 [TBL] [Abstract][Full Text] [Related]
5. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Anitua E; Sánchez M; Orive G; Andía I Biomaterials; 2007 Nov; 28(31):4551-60. PubMed ID: 17659771 [TBL] [Abstract][Full Text] [Related]
6. In vitro display technologies reveal novel biopharmaceutics. Rothe A; Hosse RJ; Power BE FASEB J; 2006 Aug; 20(10):1599-610. PubMed ID: 16873883 [TBL] [Abstract][Full Text] [Related]
7. [Progress in study of self-assembling peptides]. Chen Y; Zhang C; Li T; Wan C Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):209-11. PubMed ID: 16532843 [TBL] [Abstract][Full Text] [Related]
8. Binding sugars: from natural lectins to synthetic receptors and engineered neolectins. Arnaud J; Audfray A; Imberty A Chem Soc Rev; 2013 Jun; 42(11):4798-813. PubMed ID: 23353569 [TBL] [Abstract][Full Text] [Related]
9. Molecular biomimetics: GEPI-based biological routes to technology. Tamerler C; Khatayevich D; Gungormus M; Kacar T; Oren EE; Hnilova M; Sarikaya M Biopolymers; 2010; 94(1):78-94. PubMed ID: 20091881 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial library approaches for improving soluble protein expression in Escherichia coli. Hart DJ; Tarendeau F Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):19-26. PubMed ID: 16369090 [TBL] [Abstract][Full Text] [Related]
14. Molecular recognition with designed peptides and proteins. Cooper WJ; Waters ML Curr Opin Chem Biol; 2005 Dec; 9(6):627-31. PubMed ID: 16257571 [TBL] [Abstract][Full Text] [Related]
15. Expanding the chemical toolbox for the synthesis of large and uniquely modified proteins. Bondalapati S; Jbara M; Brik A Nat Chem; 2016 Apr; 8(5):407-18. PubMed ID: 27102674 [TBL] [Abstract][Full Text] [Related]
16. Engineering of affibody molecules for therapy and diagnostics. Feldwisch J; Tolmachev V Methods Mol Biol; 2012; 899():103-26. PubMed ID: 22735949 [TBL] [Abstract][Full Text] [Related]
17. Engineering growth factors for regenerative medicine applications. Mitchell AC; Briquez PS; Hubbell JA; Cochran JR Acta Biomater; 2016 Jan; 30():1-12. PubMed ID: 26555377 [TBL] [Abstract][Full Text] [Related]
18. Orthogonality in organic, polymer, and supramolecular chemistry: from Merrifield to click chemistry. Wong CH; Zimmerman SC Chem Commun (Camb); 2013 Feb; 49(17):1679-95. PubMed ID: 23282586 [TBL] [Abstract][Full Text] [Related]
19. Emerging technologies for enabling proangiogenic therapy. Roy RS; Roy B; Sengupta S Nanotechnology; 2011 Dec; 22(49):494004. PubMed ID: 22101316 [TBL] [Abstract][Full Text] [Related]
20. Engineering knottins as novel binding agents. Moore SJ; Cochran JR Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]